2024 - Cilia Proteins as Biomarkers of Vascular Health
Date2024-12-13
Deadline2024-12-13
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Clinical Trials; Biomarkers
Topics/Call fo Papers
Discover an informative webinar in which the speaker will be discussing the latest findings on cilia’s biomarker potential and its application in the clinic.
Cilia are microtubule-based organelles found in most cells in the body. Endothelial cilia are a known blood flow sensor and studies have identified that upon high shear stress, endothelial cilia get dismantled, a process called deciliation.
On deciliation, proteins found inside a microtubule-based organelle called cilia are released into the blood. When these proteins from inside the cilium are spilled into blood, they stick to cells in blood, which can be detected by flow and immunoassays. These ciliary proteins can be observed in conditions where the underlying vasculature is weakened due to disturbed flow.
In some cases, ciliary protein levels correlate with recovery from the blood–brain barrier damage. Based on recent scientific discoveries, assays are being developed for detecting ciliary proteins in human blood and other body fluids. Moreover, predictions for long-term or short-term outcomes are expected to administer appropriate
clinical care.
Register for this webinar today to explore the latest developments related to the biomarker potential of cilia and their potential clinical applications.
Keywords: Biomarker, Clinical Research, Biomarkers, Immunoassays, Biomarker Discovery, Assay Development, Assay, Protein, Diagnostic Assays, Blood Biomarkers, Bioassays, Basic Research
Cilia are microtubule-based organelles found in most cells in the body. Endothelial cilia are a known blood flow sensor and studies have identified that upon high shear stress, endothelial cilia get dismantled, a process called deciliation.
On deciliation, proteins found inside a microtubule-based organelle called cilia are released into the blood. When these proteins from inside the cilium are spilled into blood, they stick to cells in blood, which can be detected by flow and immunoassays. These ciliary proteins can be observed in conditions where the underlying vasculature is weakened due to disturbed flow.
In some cases, ciliary protein levels correlate with recovery from the blood–brain barrier damage. Based on recent scientific discoveries, assays are being developed for detecting ciliary proteins in human blood and other body fluids. Moreover, predictions for long-term or short-term outcomes are expected to administer appropriate
clinical care.
Register for this webinar today to explore the latest developments related to the biomarker potential of cilia and their potential clinical applications.
Keywords: Biomarker, Clinical Research, Biomarkers, Immunoassays, Biomarker Discovery, Assay Development, Assay, Protein, Diagnostic Assays, Blood Biomarkers, Bioassays, Basic Research
Other CFPs
- Developing Predictive Cancer Models and More Persistent CAR T-cell Therapies through Enhanced Metabolic Fitness
- Generative AI in Clinical Research: From Data to Patient Cohorts
- Microfluidic Devices with Glass: New Trends for Diagnostic and Life Science Applications
- Greening Solid-Phase Peptide Synthesis: Improving Sustainability While Maintaining Crude Purity
- Navigating the CNS Clinical Trial Landscape in the Asia-Pacific (APAC): Challenges, Opportunities, and Best Practices
Last modified: 2024-10-30 05:36:53